|
⚲
|
| Keyboard |
| Sharp Shalini
✚
|
|
|---|---|
| CIK # | 0001377202 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001377202] | |
| 4 | [0001377202] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Septerna Inc SEPN
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 16,623 | $0.00 | |
|
Organon & Co OGN
Phantom Stock · derivative
|
2025-06-13 | Grant | 23,904.38 | $10.04 | 240,000 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-22 | Option exercise | 1,435 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-05-22 | Option exercise | 1,435 | $0.00 | |
|
BeOne Medicines Ltd BGNE
Share Option (Right to Buy) · derivative
|
2025-05-21 | Grant | 22,750 | $0.00 | |
|
BeOne Medicines Ltd BGNE
Ordinary Shares
|
2025-05-21 | Grant | 10,985 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2025-05-21 | Grant | 3,305 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-21 | Grant | 1,659 | $0.00 | |
|
BeOne Medicines Ltd BGNE
Share Option (Right to Buy) · derivative
|
2024-09-30 | Grant | 17,238 | $0.00 | |
|
BeOne Medicines Ltd BGNE
Ordinary Shares
|
2024-09-30 | Grant | 8,151 | $0.00 | |
|
Organon & Co OGN
Phantom Stock · derivative
|
2024-06-07 | Grant | 9,638.55 | $20.75 | 200,000 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2024-05-22 | Grant | 1,435 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2024-05-22 | Grant | 2,982 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-05-17 | Sell | 1,106 | $141.90 | 156,941 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-05-17 | Option exercise | 2,100 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2024-05-17 | Option exercise | 2,100 | $0.00 | |
|
Mirati Therapeutics Inc MRTX
Option to Purchase Common Stock · derivative
|
2024-01-23 | Disposed to issuer | 7,520 | ||
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2024-01-23 | Disposed to issuer | 6,808 | ||
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2024-01-23 | Disposed to issuer | 5,252 | ||
|
Mirati Therapeutics Inc MRTX
Common Stock
|
2024-01-23 | Disposed to issuer | 4,162 | ||
| showing 20 of 200 most recent transactions | |||||